Source: CELEGENCE Blog

CELEGENCE Blog Navigating the Complex CMC Landscape of ATMPs and CGTs

Navigating the Complex CMC Landscape of ATMPs and CGTs The development of Advanced Therapy Medicinal Products (ATMPs), and Cell and Gene Therapies (CGTs) opens up exciting possibilities for treating previously untreatable conditions. The complexity of these therapies is very challenging and requires meticulous attention to the pharmaceutical development to ensure their quality,The post Navigating the Complex CMC Landscape of ATMPs and CGTs appeared first on Celegence.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Sonia Veluchamy's photo - Co-Founder & CEO of Celegence

Co-Founder & CEO

Sonia Veluchamy

CEO Approval Rating

85/100

Read more